Navigation Links
InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan
Date:8/21/2009

HATBORO, Pa., Aug. 21 /PRNewswire-FirstCall/ -- InfoLogix, Inc. ("InfoLogix" or the "Company") (Nasdaq: IFLG), a leading technology provider of enterprise mobility solutions for the healthcare and commercial industries, today announced that it has filed a preliminary proxy statement with the U.S. Securities and Exchange Commission ("SEC") in connection with a special meeting of stockholders of InfoLogix to approve a proposed recapitalization plan of the Company and certain related matters.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090618/NE35135LOGO )

On August 20, 2009, InfoLogix signed a non-binding term sheet with NewSpring Capital, LLC ("NewSpring") outlining the terms and conditions under which NewSpring and a syndicate of other undetermined investors would purchase up to $23 million of convertible preferred stock of InfoLogix, as well as warrants to purchase shares of common stock of the Company. The Company has not entered into any definitive agreements in connection with the proposed recapitalization plan. To the extent that it is consummated at all, the recapitalization plan as described in the preliminary proxy statement filed on August 21, 2009 is subject to change based upon negotiation of the final terms and execution of the definitive agreements.

Additional Information

Investors are advised not to put undue reliance on the description of the term sheet provided in the preliminary proxy statement. If the terms and conditions of the proposed recapitalization plan change materially from those disclosed the preliminary proxy statement, the Board of Directors of InfoLogix will seek stockholder approval of those changes.

InfoLogix has filed a preliminary proxy statement concerning the recapitalization plan, which is subject to SEC review. STOCKHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE PRELIMINARY PROXY STATEMENT FILED WITH THE SEC, AND, WHEN THEY BECOME AVAILABLE, THE DEFINITIVE PROXY STATEMENT AND OTHER RELEVANT MATERIALS, BECAUSE THEY DO AND WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE PROPOSED RECAPITALIZATION PLAN. The definitive proxy statement will be mailed to stockholders as of a record date to be established for voting on the proposed transaction. Investors may obtain free copies of the Company's preliminary proxy statement and its other SEC filings electronically by accessing the SEC's home page athttp://www.sec.gov. Copies can also be obtained, free of charge, upon written request to InfoLogix, Inc., Attn: Corporate Secretary, 101 East County Line Road, Suite 210, Hatboro, PA 19040.

Participation in Solicitation

This press release may constitute soliciting material under SEC Rule 14a-12, and InfoLogix and its directors, executive officers, and advisors may be deemed to be participants in the solicitation of proxies from the holders of InfoLogix common stock in respect of the proposed recapitalization plan. Investors may obtain additional information regarding the interest of those participants by reading the Company's preliminary proxy statement and, when they become available, the Company's definitive proxy statement and other relevant proxy materials, and the Company's Annual Reports on Form 10-K as filed with the SEC, and the Company's Quarterly Reports on Form 10-Q as filed with the SEC.

Disclaimer

This press release is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed recapitalization plan and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of InfoLogix, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About InfoLogix, Inc.

InfoLogix is a leading provider of enterprise mobility solutions for the healthcare and commercial industries. InfoLogix uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes. With 19 issued patents, InfoLogix provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to over 2,000 clients in North America including Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System and Stanford School of Medicine. InfoLogix is a publicly-traded company (Nasdaq: IFLG).

Safe Harbor

InfoLogix makes forward-looking statements, including those relating to plans for regaining compliance with the Nasdaq rules, in this press release which represent our expectations or beliefs about future events and financial performance. Forward-looking statements are identifiable by words such as "believe," "anticipate," "expect," "intend," "plan," "will," "may" and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Forward-looking statements are subject to known and unknown risks and uncertainties, including the risks described in our Annual Report on Form 10-K for the period ended December 31, 2008, our Quarterly Report on Form 10-Q for the period ended June 30, 2009 and other filings we make with the Securities and Exchange Commission. In addition, actual results could differ materially from those suggested by the forward-looking statements, and therefore you should not place undue reliance on the forward-looking statements. We do not make any commitment to revise or update any forward-looking statements to reflect events or circumstances occurring or existing after the date of any forward-looking statement is made.

    Contact:
    John A. Roberts
    Chief Financial Officer
    215-604-0691 x1102


'/>"/>
SOURCE InfoLogix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. InfoLogix Achieves Motorola Enterprise Mobility Validation
2. InfoLogix Announces Second Quarter Financial Results
3. InfoLogix Selected by Hilo Medical Center for Multi-Year Engagement to Deliver Wireless as a Service
4. New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care
5. Healthcare Informatics Associates, an InfoLogix Company, Selected by Hilo Medical Center for MEDITECH 6.0 EMR Implementation
6. InfoLogix Ranked as 7th Leading Consulting Company in Healthcare IT
7. InfoLogix and HIA Advise Hospitals How to Obtain Maximum Share of $19B Healthcare Stimulus
8. InfoLogix CEO David Gulian Named Ernst & Young Entrepreneur Of The Year 2009 Award Finalist in Greater Philadelphia
9. InfoLogix Named as One of the Top 50 Healthcare Information Technology Companies in the World
10. InfoLogix Selected by Gwinnett Medical Center to Transform Clinical Care Through Next-Generation Mobile Communications Solution
11. InfoLogix Partners with TeleHealth Services to Enable On-Demand Healthcare Infrastructure for Hospitals Across the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
(Date:2/8/2016)... Palatin Technologies, Inc. (NYSE MKT: PTN), ... for the treatment of diseases with significant unmet ... the United States Patent and Trademark Office (USPTO) ... Patent Application Serial Number 14/313,258 (the ,258 application).  ... female sexual dysfunction using the formulation and dose ...
Breaking Medicine Technology: